Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EKF.L Stock Summary
Top 10 Correlated ETFs
EKF.L
In the News
EKF.L Financial details
Company Rating
Neutral
Market Cap
117.06M
Income
-7.75M
Revenue
119.25M
Book val./share
-
Cash/share
-
Dividend
0.01
Dividend %
3.97%
Employees
356
Optionable
No
Shortable
Yes
Earnings
20 Mar 2024
P/E
-14.43
Forward P/E
2760
PEG
7.94
P/S
2.06
P/B
1.88
P/C
-
P/FCF
35.53
Quick Ratio
1.9
Current Ratio
2.71
Debt / Equity
0.05
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
0.01
EPS next Q
-
EPS this Y
-124.88%
EPS next Y
-143.27%
EPS next 5Y
-164.33%
EPS last 5Y
-8.48%
Revenue last 5Y
3.21%
Revenue Q/Q
-4.22%
EPS Q/Q
-850%
-
-
-
-
SMA20
-6.35%
SMA50
-15.44%
SMA100
-4.69%
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-11%
ROC
0.02%
Gross Margin
36%
Oper. Margin
3%
Profit Margin
-14%
Payout
-57%
Shs Outstand
453.73M
Shs Float
432.71M
-
-
-
-
Target Price
-
52W Range
22.2-38.221
52W High
-27.37%
52W Low
+25.45%
RSI
52.41
Rel Volume
2.64
Avg Volume
232.25K
Volume
613.92K
Perf Week
3.56%
Perf Month
-3.16%
Perf Quarter
0.36%
Perf Half Y
8.66%
-
-
-
-
Beta
0.584
-
-
Volatility
1.15%, 1.19%
Prev Close
2.99%
Price
27.6
Change
2.6%
EKF.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.1 | 0.14 | 0.18 | 0.15 | 0.12 | |
Net income per share | 0.01 | 0.02 | 0.03 | -0.02 | 0.01 | |
Operating cash flow per share | 0.01 | 0.03 | 0.02 | 0.02 | 0.01 | |
Free cash flow per share | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Cash per share | 0.03 | 0.05 | 0.04 | 0.03 | 0.02 | |
Book value per share | 0.16 | 0.17 | 0.21 | 0.16 | 0.15 | |
Tangible book value per share | 0.07 | 0.09 | 0.12 | 0.09 | 0.1 | |
Share holders equity per share | 0.16 | 0.17 | 0.21 | 0.16 | 0.15 | |
Interest debt per share | 0 | 0.01 | 0.01 | 0 | 0.01 | |
Market cap | 155.53M | 326.12M | 342.75M | 228.59M | 143.72M | |
Enterprise value | 145.11M | 305.79M | 325.04M | 218.56M | 140.1M | |
P/E ratio | 42.29 | 29.34 | 21.62 | -23.87 | 61.11 | |
Price to sales ratio | 3.46 | 5 | 4.19 | 3.43 | 2.73 | |
POCF ratio | 30.5 | 23.62 | 33.48 | 23.6 | 22.77 | |
PFCF ratio | 57.07 | 29.21 | 74.69 | 59.22 | -216.45 | |
P/B Ratio | 2.2 | 4.2 | 3.64 | 3.12 | 2.14 | |
PTB ratio | 2.2 | 4.2 | 3.64 | 3.12 | 2.14 | |
EV to sales | 3.23 | 4.69 | 3.97 | 3.28 | 2.66 | |
Enterprise value over EBITDA | 14.09 | 14.18 | 11.74 | 25.51 | 13.7 | |
EV to operating cash flow | 28.45 | 22.14 | 31.75 | 22.56 | 22.2 | |
EV to free cash flow | 53.25 | 27.39 | 70.83 | 56.62 | -210.99 | |
Earnings yield | 0.02 | 0.03 | 0.05 | -0.04 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0.01 | 0.02 | 0 | |
Debt to equity | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | |
Net debt to EBITDA | -1.01 | -0.94 | -0.64 | -1.17 | -0.35 | |
Current ratio | 2.04 | 2.26 | 3.48 | 2.71 | 2.69 | |
Interest coverage | 17.06 | 10.61 | 60.92 | 18.74 | 63.41 | |
Income quality | 0.92 | 0.9 | 0.48 | -1.08 | 2.68 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.02 | 0.04 | |
Payout ratio | 0 | 0.41 | 0.32 | -0.57 | 2.32 | |
Sales general and administrative to revenue | 0.41 | 0.32 | 0.22 | 0.35 | 0 | |
Research and developement to revenue | 0.05 | 0.02 | 0.02 | 0.02 | 0.03 | |
Intangibles to total assets | 0.43 | 0.37 | 0.36 | 0.38 | 0.3 | |
Capex to operating cash flow | -0.47 | -0.19 | -0.55 | -0.6 | -1.11 | |
Capex to revenue | -0.05 | -0.04 | -0.07 | -0.09 | -0.13 | |
Capex to depreciation | -0.53 | -0.57 | -0.96 | -0.88 | -1.27 | |
Stock based compensation to revenue | 0.05 | 0.07 | -0.08 | 0 | 0 | |
Graham number | 0.17 | 0.31 | 0.4 | 0.27 | 0.13 | |
ROIC | 0.06 | 0.16 | 0.17 | 0.03 | 0.09 | |
Return on tangible assets | 0.07 | 0.17 | 0.22 | -0.17 | 0.04 | |
Graham Net | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 | |
Working capital | 13.39M | 24.54M | 33.91M | 20.02M | 16.06M | |
Tangible asset value | 33.41M | 41.15M | 52.85M | 40.75M | 43.79M | |
Net current asset value | 10.29M | 20.89M | 27.18M | 16.99M | 12.92M | |
Invested capital | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | |
Average receivables | 7.38M | 10.77M | 12.8M | 11.22M | 9.91M | |
Average payables | 8.78M | 10.95M | 11.76M | 8.68M | 6.9M | |
Average inventory | 6.09M | 7.28M | 10.86M | 11.34M | 9.1M | |
Days sales outstanding | 61.9 | 77.88 | 52.07 | 58.93 | 62.88 | |
Days payables outstanding | 128.67 | 189.25 | 78.02 | 71.02 | 71.41 | |
Days of inventory on hand | 104.61 | 111.27 | 113.77 | 80.84 | 113.56 | |
Receivables turnover | 5.9 | 4.69 | 7.01 | 6.19 | 5.8 | |
Payables turnover | 2.84 | 1.93 | 4.68 | 5.14 | 5.11 | |
Inventory turnover | 3.49 | 3.28 | 3.21 | 4.52 | 3.21 | |
ROE | 0.05 | 0.14 | 0.17 | -0.13 | 0.04 | |
Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0.08 | 0.06 | 0.06 | 0 | |
Net income per share | 0.01 | 0 | -0.03 | 0 | 0 | |
Operating cash flow per share | 0.02 | 0.02 | 0 | 0.01 | 0 | |
Free cash flow per share | 0.01 | 0.01 | 0 | 0 | 0 | |
Cash per share | 0.04 | 0.04 | 0.03 | 0.02 | 0 | |
Book value per share | 0.2 | 0.19 | 0.16 | 0.14 | 0 | |
Tangible book value per share | 0.11 | 0.09 | 0.09 | 0.08 | 0 | |
Share holders equity per share | 0.2 | 0.19 | 0.16 | 0.14 | 0 | |
Interest debt per share | 0.01 | 0 | 0 | 0 | 0 | |
Market cap | 344.79M | 147.03M | 227.47M | 143.17M | 0 | |
Enterprise value | 327.07M | 129.81M | 217.43M | 134.67M | -3.63M | |
P/E ratio | 12.71 | 16.61 | -4.62 | -99.98 | 0 | |
Price to sales ratio | 7.97 | 3.92 | 7.8 | 5.33 | 0 | |
POCF ratio | 37.76 | 17.33 | 189.08 | 57.13 | 0 | |
PFCF ratio | 63.29 | 26.74 | -138.78 | -146.54 | 0 | |
P/B Ratio | 3.66 | 1.72 | 3.1 | 2.23 | 0 | |
PTB ratio | 3.66 | 1.72 | 3.1 | 2.23 | 0 | |
EV to sales | 7.56 | 3.46 | 7.46 | 5.01 | -0.14 | |
Enterprise value over EBITDA | 24.2 | 15.61 | 36.37 | 30.94 | -0.62 | |
EV to operating cash flow | 35.82 | 15.3 | 180.74 | 53.74 | -0.95 | |
EV to free cash flow | 60.04 | 23.61 | -132.66 | -137.84 | -11.59 | |
Earnings yield | 0.02 | 0.02 | -0.05 | 0 | 0 | |
Free cash flow yield | 0.02 | 0.04 | -0.01 | -0.01 | 0 | |
Debt to equity | 0.03 | 0.02 | 0.02 | 0.01 | 0.05 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.04 | |
Net debt to EBITDA | -1.31 | -2.07 | -1.68 | -1.95 | -0.62 | |
Current ratio | 3.48 | 2.5 | 2.71 | 1.82 | 2.69 | |
Interest coverage | 51.8 | 72.84 | 78.88 | 59.89 | 64.53 | |
Income quality | 1.35 | 3.83 | -0.1 | -7 | 1.4 | |
Dividend Yield | 0.01 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0.75 | 0 | -0.44 | 0 | 2.01 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.36 | 0.4 | 0.38 | 0.38 | 0.3 | |
Capex to operating cash flow | -0.4 | -0.35 | -2.36 | -1.39 | -0.92 | |
Capex to revenue | -0.09 | -0.08 | -0.1 | -0.13 | -0.14 | |
Capex to depreciation | -1.21 | -0.89 | -0.86 | -1.06 | -1.59 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.26 | 0.14 | 0.31 | 0.05 | 0 | |
ROIC | 0.07 | 0.03 | 0.03 | 0.11 | 0.07 | |
Return on tangible assets | 0.09 | 0.03 | -0.22 | -0.01 | 0.05 | |
Graham Net | 0.03 | 0.03 | 0.02 | 0.01 | 0 | |
Working capital | 33.91M | 26.84M | 20.02M | 11.95M | 16.06M | |
Tangible asset value | 52.85M | 43.29M | 40.75M | 34.1M | 43.79M | |
Net current asset value | 27.18M | 22.04M | 16.99M | 9.59M | 12.92M | |
Invested capital | 0.03 | 0.02 | 0.02 | 0.01 | 0.05 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 24.28 | 30.37 | 33.2 | 26.77 | 31.69 | |
Days payables outstanding | 36.39 | 64.55 | 46.34 | 70.9 | 37.24 | |
Days of inventory on hand | 53.07 | 59.17 | 52.75 | 57.04 | 59.23 | |
Receivables turnover | 3.71 | 2.96 | 2.71 | 3.36 | 2.84 | |
Payables turnover | 2.47 | 1.39 | 1.94 | 1.27 | 2.42 | |
Inventory turnover | 1.7 | 1.52 | 1.71 | 1.58 | 1.52 | |
ROE | 0.07 | 0.03 | -0.17 | -0.01 | 0.04 | |
Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | 0 |
EKF.L Frequently Asked Questions
What is EKF Diagnostics Holdings plc stock symbol ?
EKF Diagnostics Holdings plc is a GB stock and trading under the symbol EKF.L
What is EKF Diagnostics Holdings plc stock quote today ?
EKF Diagnostics Holdings plc stock price is $27.6 today.
Is EKF Diagnostics Holdings plc stock public?
Yes, EKF Diagnostics Holdings plc is a publicly traded company.